Kevin Quon
Insider ownership, small-cap, long-term horizon, dividend investing

Is Now The Time To Buy Atrion Corporation?

Biotechnology has led the most recent decline on the market as witnessed by the performance of iShares Nasdaq Biotechnology Index (NASDAQ:IBB). However, one medical product name that has outperformed this ETF has been a small company called Atrion Corporation (NASDAQ:ATRI). Over the past decade, the company has seen its share price rise over 500% from $45 in 2004 to over $300 in 2014. Both of these trends can be seen in the two price charts found below.

Atrion Corporation develops and manufactures products primarily used for medical applications. The company's expertise revolves primarily around three fields found in fluid delivery devices, cardiovascular products, and ophthalmic products. For 2013, these three fields accounted for 39%,...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details